Recursion Pharmaceuticals Inc Clas (RXRX)
Cash & Equivalents
$545.68M
Quarterly · Period ending: · USD
RXRX Cash & Equivalents
Latest reported$545.68Mperiod ending
Latest reported$545.68Mperiod ending
RXRX Quarterly Cash & Equivalents (-$69.88M → $545.68M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
RXRX cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 545,683,000 | |
| 654,473,000 | |
| 743,294,000 | |
| 659,836,000 | |
| 528,216,000 | |
| 500,453,000 | |
| 594,350,000 | |
| 427,647,000 | |
| 474,341,000 | |
| 299,521,000 | |
| 391,565,000 | |
| 387,322,000 | |
| 405,870,000 | |
| 473,145,000 | |
| 549,912,000 | |
| 454,646,000 | |
| 453,875,000 | |
| 507,891,000 | |
| 285,116,000 | |
| 394,721,000 | |
| 632,738,000 | |
| 214,088,000 | |
| 262,126,000 | |
| -69,883,000 |